Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Amphista Therapeutics partners with Domainex to advance portfolio of drug discovery projects targeting protein degradation

    Oct 6, 2022, 09:17 AM by
    Amphista Therapeutics Ltd has selected Domainex Ltd as one of its trusted partners to provide integrated drug discovery services to support its research programmes. Domainex will provide expertise in protein production, assay biology and medicinal chemistry.
    Full story
  • Select European Research Institutes Become the First to Join International Data Network

    Oct 6, 2022, 01:00 AM by User Not Found
    Bio-IT World | Research institutes representing five western European countries—Finland, Germany, Norway, Spain, and Sweden—will become the first to join the Federated European Genome-phenome Archive, an international distributed data network designed to share highly-sensitive human ’omics data internationally.
    Full story
  • Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs

    Oct 5, 2022, 09:39 AM by
    Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities
    Full story
  • LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR BARICITINIB (OLUMIANT®) FOR THE TREATMENT OF SEVERE ALOPECIA AREATA (AA) IN ADULT PATIENTS

    Oct 5, 2022, 09:39 AM by
    Full story
  • Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide

    Oct 5, 2022, 09:38 AM by
    Absolute Biotech launched today as a unified company joining together leading antibody-centric brands: Absolute Antibody, LSBio, Kerafast, Nordic-MUbio, Everest Biotech and Exalpha from around the world.
    Full story
  • dMed | Clinipace announce corporate name change to Caidya

    Oct 4, 2022, 09:52 AM by
    dMed |Clinipace, the established clinical research organization serving global innovators, such as biotechs, announced today that it is changing its corporate name to Caidya
    Full story
  • Wearable Sensor Continuously Measures Subcutaneous Tumor Progression and Regression

    Oct 4, 2022, 01:00 AM by User Not Found
    Bio-IT World | A team of researchers from Stanford University and the Georgia Institute of Technology designed a malleable, battery-operated wearable sensor that continuously monitors subcutaneous tumor progression, regression, and treatment efficacy.
    Full story
  • LIQUID STABLE, MULTI-LEVEL CLINICAL REFERENCE MATERIALS FOR TOXICOLOGY TESTING AVAILABLE FROM VERICHEM LABOTATORIES

    Oct 3, 2022, 12:30 PM by
    VERICHEM announced the availability of ready-to-use, multi-level, clinical reference materials for use with Toxicology assays on a wide array of diagnostic testing systems.
    Full story
  • Announcing the 2022 Founder-Led Biotech Summit

    Oct 3, 2022, 12:26 PM by
    Pillar VC and Petri have announced the 2022 Founder-Led Biotech Summit will take place during the week of October 31–November 4. This free, virtual event will be open to biotech founders, PhDs, scientists, investors, and leaders from anywhere in the world.
    Full story
  • BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

    Oct 3, 2022, 12:26 PM by
    Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.
    Full story
  • Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

    Sep 30, 2022, 12:37 PM by
    Full story
  • Empire Screen Highlights Wide Range of Warning, Danger, and Safety Decals

    Sep 30, 2022, 12:34 PM by
    Full story
  • Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences

    Sep 29, 2022, 12:26 PM by
    Form Bio's vision is to empower life scientists with a software platform for managing large datasets, executing verified workflows, visualizing results and collaborating with their peers. The platform brings these capabilities together in one cohesive unit with a user experience designed to simplify computational work and bolster life science breakthroughs across companies, labs and universities.
    Full story
  • Biopharma PEG Offers GMP & Non-GMP Grade PEG Derivatives Manufacture Services

    Sep 29, 2022, 12:25 PM by
    Full story
  • Huateng Pharma Develops Sitagliptin & Linagliptin Anti-diabetic Intermediates

    Sep 29, 2022, 12:25 PM by
    Full story
  • VisualDx Partners with American College of Emergency Physicians to Build Library of Monkeypox Images Global Leader in Web-Based Clinical Decision Support to Launch Monkeypox Emergency Medicine Project to Help Clinicians with Diagnosis and Treatment

    Sep 29, 2022, 12:12 PM by
    Full story
  • Bally Ribbon Mills Offers Custom-Designed Woven Materials for Critical Rigging and Tie Down Applications

    Sep 29, 2022, 12:12 PM by
    Full story
  • Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment

    Sep 29, 2022, 12:00 PM by
    Monon Bioventure receives funding to develop Purdue-discovered glioblastoma treatment
    Full story
  • Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts

    Sep 29, 2022, 11:59 AM by
    Full story
  • New 30-Plex Immuno-Oncology Protein Target Panel, Temple Medicine’s Pulmonary Artery Blood Clot Reduction Device, More

    Sep 29, 2022, 01:00 AM by User Not Found
    Bio-IT World | A cloud-based software solution to streamline flow cytometry workflow; the world’s most extensive repeated set of highly-detailed, multi-organ images from a large cohort of participants; a gene editing therapy for inflammatory cardiac diseases; and more.
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138 (current)
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy